P. Verghese, J. Castellano, and D. Holtzman, Apolipoprotein E in Alzheimer's disease and other neurological disorders, The Lancet Neurology, vol.10, issue.3, pp.241-252, 2011.
DOI : 10.1016/S1474-4422(10)70325-2

P. Hogh, E. Garde, E. Mortensen, O. Jorgensen, K. Krabbe et al., The apolipoprotein E ?4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities, Acta Neurologica Scandinavica, vol.45, issue.4, pp.248-253, 2007.
DOI : 10.1161/01.STR.0000012808.81667.4B

O. Godin, C. Tzourio, P. Maillard, A. Alperovitch, B. Mazoyer et al., Apolipoprotein E Genotype Is Related to Progression of White Matter Lesion Load, Stroke, vol.40, issue.10, pp.3186-3190, 2009.
DOI : 10.1161/STROKEAHA.109.555839

H. Schmidt, R. Schmidt, and F. Fazekas, Apolipoprotein E4allele in the normal elderly: neuropsychologic and brain MRI correlates, Clinical Genetics, vol.340, issue.5, pp.293-299, 1996.
DOI : 10.1111/j.1399-0004.1996.tb02377.x

K. Lunetta, P. Erlich, and K. Cuenco, Heritability of Magnetic Resonance Imaging (MRI) Traits in Alzheimer Disease Cases and Their Siblings in the MIRAGE Study, Alzheimer Disease & Associated Disorders, vol.21, issue.2, pp.85-91, 2007.
DOI : 10.1097/WAD.0b013e3180653bf7

L. Farrer, L. Cupples, and J. Haines, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium, JAMA: The Journal of the American Medical Association, vol.278, issue.16, pp.1349-1356, 1997.
DOI : 10.1001/jama.278.16.1349

C. Sudlow, M. Gonzalez, N. Kim, J. Clark, and C. , Does Apolipoprotein E Genotype Influence the Risk of Ischemic Stroke, Intracerebral Hemorrhage, or Subarachnoid Hemorrhage?: Systematic Review and Meta-Analyses of 31 Studies Among 5961 Cases and 17 965 Controls, Stroke, vol.37, issue.2, pp.364-370, 2006.
DOI : 10.1161/01.STR.0000199065.12908.62

A. Biffi, A. Sonni, and C. Anderson, Variants at APOE influence risk of deep and lobar intracerebral hemorrhage, Annals of Neurology, vol.103, issue.6
DOI : 10.1002/ana.22134

A. Biffi, C. Anderson, and J. Jagiella, APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study, The Lancet Neurology, vol.10, issue.8, pp.702-709, 2011.
DOI : 10.1016/S1474-4422(11)70148-X

S. Debette and H. Markus, The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis, BMJ, vol.341, issue.jul26 1, p.3666, 2010.
DOI : 10.1136/bmj.c3666

M. Schuur, J. Van-swieten, and S. Schol-gelok, Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.1, pp.41-44, 2011.
DOI : 10.1136/jnnp.2009.176362

M. Poels, M. Vernooij, and M. Ikram, Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study, Stroke, vol.41, issue.10, Supplement 1, pp.103-106, 2010.
DOI : 10.1161/STROKEAHA.110.595181

M. Vuorinen, A. Solomon, and S. Rovio, Changes in Vascular Risk Factors from Midlife to Late Life and White Matter Lesions: A 20-Year Follow-Up Study, Dementia and Geriatric Cognitive Disorders, vol.31, issue.2, pp.119-125, 2011.
DOI : 10.1159/000323810

S. Vermeer, W. Longstreth, . Jr, and P. Koudstaal, Silent brain infarcts: a systematic review, The Lancet Neurology, vol.6, issue.7, pp.611-619, 2007.
DOI : 10.1016/S1474-4422(07)70170-9

S. Debette, J. Bis, and M. Fornage, Genome-Wide Association Studies of MRI-Defined Brain Infarcts: Meta-Analysis From the CHARGE Consortium * Supplemental Appendix, Stroke, vol.41, issue.2, pp.210-217, 2010.
DOI : 10.1161/STROKEAHA.109.569194

M. Fornage, S. Debette, and J. Bis, Genome-wide association studies of cerebral white matter lesion burden, Annals of Neurology, vol.80, issue.204, pp.928-939, 2011.
DOI : 10.1002/ana.22403
URL : https://hal.archives-ouvertes.fr/hal-01154260

3. Study and G. , Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003.

S. Debette, A. Beiser, and C. Decarli, Association of MRI Markers of Vascular Brain Injury With Incident Stroke, Mild Cognitive Impairment, Dementia, and Mortality: The Framingham Offspring Study, Stroke, vol.41, issue.4, pp.600-606, 2010.
DOI : 10.1161/STROKEAHA.109.570044

T. Jeerakathil, P. Wolf, and A. Beiser, Cerebral Microbleeds: Prevalence and Associations With Cardiovascular Risk Factors in the Framingham Study, Stroke, vol.35, issue.8, pp.1831-1835, 2004.
DOI : 10.1161/01.STR.0000131809.35202.1b

P. Sachdev, H. Brodaty, and S. Reppermund, The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70???90 years, International Psychogeriatrics, vol.44, issue.08, pp.1248-1264, 2010.
DOI : 10.1017/S1041610292000991

R. Lemmens, A. Gorner, M. Schrooten, and V. Thijs, Association of Apolipoprotein E ??2 With White Matter Disease but Not With Microbleeds, Stroke, vol.38, issue.4, pp.1185-1188, 2007.
DOI : 10.1161/01.STR.0000259816.31370.44

J. Goos, M. Kester, and F. Barkhof, Patients With Alzheimer Disease With Multiple Microbleeds, Stroke, vol.40, issue.11, pp.3455-3460, 2009.
DOI : 10.1161/STROKEAHA.109.558197

R. Schmidt, H. Schmidt, and F. Fazekas, Apolipoprotein E Polymorphism and Silent Microangiopathy-Related Cerebral Damage : Results of the Austrian Stroke Prevention Study, Stroke, vol.28, issue.5, pp.951-956, 1997.
DOI : 10.1161/01.STR.28.5.951

C. Decarli, T. Reed, B. Miller, P. Wolf, G. Swan et al., Impact of Apolipoprotein E ??4 and Vascular Disease on Brain Morphology in Men From the NHLBI Twin Study, Stroke, vol.30, issue.8, pp.1548-1553, 1999.
DOI : 10.1161/01.STR.30.8.1548

R. Nebes, I. Vora, and C. Meltzer, Relationship of Deep White Matter Hyperintensities and Apolipoprotein E Genotype to Depressive Symptoms in Older Adults Without Clinical Depression, American Journal of Psychiatry, vol.158, issue.6, pp.878-884, 2001.
DOI : 10.1176/appi.ajp.158.6.878

F. De-leeuw, F. Richard, and J. De-groot, Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions, Stroke, vol.35, issue.5, pp.1057-1060, 2004.
DOI : 10.1161/01.STR.0000125859.71051.83

?. Crisby, M. Bronge, L. Wahlund, and L. , Low Levels of High Density Lipoprotein Increase the Severity of Cerebral White Matter Changes:Implications for Prevention and Treatment of Cerebrovascular Diseases, Current Alzheimer Research, vol.7, issue.6, pp.534-539, 2010.
DOI : 10.2174/156720510792231694

N. Hirono, M. Yasuda, S. Tanimukai, H. Kitagaki, and E. Mori, Effect of the Apolipoprotein E ??4 Allele on White Matter Hyperintensities in Dementia, Stroke, vol.31, issue.6, pp.1263-1268, 2000.
DOI : 10.1161/01.STR.31.6.1263

H. Sawada, F. Udaka, and Y. Izumi, Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.68, issue.5, pp.653-656, 2000.
DOI : 10.1136/jnnp.68.5.653

R. Doody, S. Azher, H. Haykal, J. Dunn, T. Liao et al., Does APO epsilon 4 correlate with MRI changes in Alzheimer's disease?, Journal of Neurology, Neurosurgery & Psychiatry, vol.69, issue.5, pp.668-671, 2000.
DOI : 10.1136/jnnp.69.5.668

Z. Szolnoki, F. Somogyvari, and A. Kondacs, Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis, Acta Neurologica Scandinavica, vol.91, issue.3, pp.222-227, 2004.
DOI : 10.1006/exnr.1998.6899

L. Bracco, C. Piccini, and M. Moretti, Alzheimer???s Disease: Role of Size and Location of White Matter Changes in Determining Cognitive Deficits, Dementia and Geriatric Cognitive Disorders, vol.20, issue.6, pp.358-366, 2005.
DOI : 10.1159/000088562

H. Wen, L. Baum, and W. Cheung, Apolipoprotein E ?4 allele is associated with the volume of white matter changes in patients with lacunar infarcts, European Journal of Neurology, vol.26, issue.11, pp.1216-1220, 2006.
DOI : 10.1016/S0960-9822(00)00081-6

T. Seifert, A. Lechner, E. Flooh, H. Schmidt, R. Schmidt et al., Lack of Association of Lobar Intracerebral Hemorrhage with Apolipoprotein E Genotype in an Unselected Population, Cerebrovascular Diseases, vol.21, issue.4, pp.266-270, 2006.
DOI : 10.1159/000091225

N. Raz, Y. Yang, C. Dahle, and S. Land, Volume of white matter hyperintensities in healthy adults: Contribution of age, vascular risk factors, and inflammation-related genetic variants, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1822, issue.3, pp.361-369, 2012.
DOI : 10.1016/j.bbadis.2011.08.007

S. Hafsteinsdottir, G. Eiriksdottir, and S. Sigurdsson, Brain tissue volumes by APOE genotype and leisure activitythe AGES-Reykjavik Study, Neurobiol Aging, vol.33, pp.829-830, 2012.
DOI : 10.1016/j.neurobiolaging.2011.06.028
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821657

L. Kuller, L. Shemanski, and T. Manolio, Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study, Stroke, vol.29, issue.2, pp.388-398, 1998.
DOI : 10.1161/01.STR.29.2.388

D. Steffens, W. Trost, M. Payne, C. Hybels, and J. Macfall, Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects, Biological Psychiatry, vol.54, issue.7, pp.674-681, 2003.
DOI : 10.1016/S0006-3223(02)01782-1

P. Sachdev, R. Parslow, W. Wen, K. Anstey, and S. Easteal, Sex differences in the causes and consequences of white matter hyperintensities, Neurobiology of Aging, vol.30, issue.6, pp.946-956, 2009.
DOI : 10.1016/j.neurobiolaging.2007.08.023

J. He, A. Iosif, and D. Lee, Brain Structure and Cerebrovascular Risk in Cognitively Impaired Patients, Archives of Neurology, vol.67, issue.10, pp.1231-1237, 2010.
DOI : 10.1001/archneurol.2010.230

A. Biffi, C. Anderson, and R. Desikan, Genetic Variation and Neuroimaging Measures in Alzheimer Disease, Archives of Neurology, vol.67, issue.6, pp.677-685, 2010.
DOI : 10.1001/archneurol.2010.108

S. Sveinbjornsdottir, S. Sigurdsson, and T. Aspelund, Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.9, pp.1002-1006, 2008.
DOI : 10.1136/jnnp.2007.121913

M. Kim, H. Bae, and J. Lee, ??2/??4 polymorphism and cerebral microbleeds on gradient-echo MRI, Neurology, vol.65, issue.9, pp.1474-1475, 2005.
DOI : 10.1212/01.wnl.0000183311.48144.7f

C. Cordonnier, W. Van-der-flier, J. Sluimer, D. Leys, F. Barkhof et al., Prevalence and severity of microbleeds in a memory clinic setting, Neurology, vol.66, issue.9, pp.1356-1360, 2006.
DOI : 10.1212/01.wnl.0000210535.20297.ae

L. Paternoster, W. Chen, and C. Sudlow, Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects * Supplemental References, Stroke, vol.40, issue.6, pp.2020-2026, 2009.
DOI : 10.1161/STROKEAHA.108.542050

N. Cherbuin, L. Leach, H. Christensen, and K. Anstey, Neuroimaging and <i>APOE</i> Genotype: A Systematic Qualitative Review, Dementia and Geriatric Cognitive Disorders, vol.24, issue.5, pp.348-362, 2007.
DOI : 10.1159/000109150

N. Rost, S. Greenberg, and J. Rosand, The Genetic Architecture of Intracerebral Hemorrhage, Stroke, vol.39, issue.7, pp.2166-2173, 2008.
DOI : 10.1161/STROKEAHA.107.501650

S. Greenberg, Cerebral Amyloid Angiopathy and Vessel Dysfunction, Cerebrovascular Diseases, vol.13, issue.2, pp.42-47, 2002.
DOI : 10.1159/000049149

M. Tanskanen, M. Makela, and L. Myllykangas, Prevalence and severity of cerebral amyloid angiopathy: a population-based study on very elderly Finns (Vantaa 85+), Neuropathology and Applied Neurobiology, vol.153, issue.4, pp.329-336, 2012.
DOI : 10.1111/j.1365-2990.2011.01219.x

M. Mccarron, J. Nicoll, and J. Stewart, The Apolipoprotein E ??2 Allele and the Pathological Features in Cerebral Amyloid Angiopathy-related Hemorrhage, Journal of Neuropathology and Experimental Neurology, vol.58, issue.7, pp.711-718, 1999.
DOI : 10.1097/00005072-199907000-00005

E. Smith, K. Nandigam, and Y. Chen, MRI Markers of Small Vessel Disease in Lobar and Deep Hemispheric Intracerebral Hemorrhage, Stroke, vol.41, issue.9, pp.1933-1938, 2010.
DOI : 10.1161/STROKEAHA.110.579078

Y. Zhu, H. Chabriat, and O. Godin, Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging, Journal of Neurology, vol.53, issue.3, pp.530-536, 2012.
DOI : 10.1007/s00415-011-6218-3

J. Attems, K. Jellinger, D. Thal, and W. Van-nostrand, Review: Sporadic cerebral amyloid angiopathy, Neuropathology and Applied Neurobiology, vol.67, issue.230, pp.75-93, 2011.
DOI : 10.1111/j.1365-2990.2010.01137.x

J. Wardlaw, P. Sandercock, M. Dennis, and J. Starr, Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?, Stroke, vol.34, issue.3, pp.806-812, 2003.
DOI : 10.1161/01.STR.0000058480.77236.B3

C. Satizabal, Y. Zhu, B. Mazoyer, C. Dufouil, and C. Tzourio, Circulating IL-6 and CRP are associated with MRI findings in the elderly: The 3C-Dijon Study, Neurology, vol.78, issue.10, pp.720-727, 2012.
DOI : 10.1212/WNL.0b013e318248e50f
URL : https://hal.archives-ouvertes.fr/hal-01166212

S. Maxwell, C. Jackson, and L. Paternoster, Genetic associations with brain microbleeds: Systematic review and meta-analyses, Neurology, vol.77, issue.2, pp.158-167, 2011.
DOI : 10.1212/WNL.0b013e318224afa3
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140069

K. Knudsen, J. Rosand, D. Karluk, and S. Greenberg, Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria, Neurology, vol.56, issue.4, pp.537-539, 2001.
DOI : 10.1212/WNL.56.4.537

S. Greenberg, M. Vernooij, and C. Cordonnier, Cerebral microbleeds: a guide to detection and interpretation, The Lancet Neurology, vol.8, issue.2, pp.165-174, 2009.
DOI : 10.1016/S1474-4422(09)70013-4

H. Chabriat, A. Joutel, M. Dichgans, E. Tournier-lasserve, and M. Bousser, CADASIL, The Lancet Neurology, vol.8, issue.7, pp.643-653, 2009.
DOI : 10.1016/S1474-4422(09)70127-9
URL : https://hal.archives-ouvertes.fr/hal-00349728

E. Corder, A. Saunders, and N. Risch, Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease, Nature Genetics, vol.6, issue.2, pp.180-184, 1994.
DOI : 10.1038/ng0694-180